Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 11:38 PM
Ignite Modification Date:
2025-12-24 @ 11:38 PM
NCT ID:
NCT07129551
Eligibility Criteria:
Inclusion Criteria:
Cohort A:
* Patients with hormone-sensitive prostate cancer scheduled for radical prostatectomy with pelvic lymph node dissection
* \<3 PSMA-PET-avid lymph node metastases (PSMA expression score \>2) in the pelvis.
Cohort B:
* Patients with hormone-sensitive recurrent prostate cancer after radical prostatectomy with planned pelvic salvage lymph node dissection
* \<3 PSMA-PET-avid lymph node metastases (PSMA expression score \>2) in the pelvis
* PSA value \<2ng/ml.
Exclusion Criteria:
* Estimated life expectancy \<10 years
* contraindication for surgical intervention
* androgen deprivation therapy (ADT) within the last 3 months
Healthy Volunteers:
False
Sex:
MALE
Minimum Age:
18 Years
Maximum Age:
78 Years
Study:
NCT07129551
Study Brief:
Protocol Section:
NCT07129551